Trial
NCT03207334
iCare4: Genomic Signatures With Midostaurin in Acute Myeloid Leukemia (UF-HEM-004)
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Florida
Collaborators
Novartis Pharmaceuticals
Condition
Acute Myeloid Leukemia
Intervention
Midostaurin
Why stopped
Insufficient funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-10-22